Crixivan and Abnormal behaviour - a phase IV clinical study of FDA data

Summary:

Abnormal behaviour is reported as a side effect among people who take Crixivan (indinavir sulfate), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Zerit, and have Hiv infection.

The phase IV clinical study analyzes which people have Abnormal behaviour when taking Crixivan. It is created by eHealthMe based on reports of 6,310 people who have side effects when taking Crixivan from the FDA, and is updated regularly.

What is Crixivan?

Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,312 Crixivan users. Check the latest studies of Crixivan.

What is Abnormal behaviour?

Abnormal behaviour is found to be associated with 1,866 drugs and 2,159 conditions by eHealthMe. Check the latest studies of Abnormal behaviour.

On Oct, 21, 2025

6,310 people reported to have side effects when taking Crixivan.
Among them, 12 people (0.19%) have Abnormal behaviour.

Could Crixivan cause Abnormal behaviour?

Among these 12 people:

How long have people been on Crixivan when they have Abnormal behaviour? *

What is the gender of people who have Abnormal behaviour when taking Crixivan? *

female: 0.0 %
male: 100 %

What is the age of people who have Abnormal behaviour when taking Crixivan? *

What are other drugs people take besides Crixivan? *

What are other side effects people have besides Abnormal behaviour? *

Aspartate Aminotransferase Increased: 11 people, 91.67%
Depression: 11 people, 91.67%
Speech Disorder: 11 people, 91.67%
Blood Lactate Dehydrogenase Increased: 11 people, 91.67%
Blood Creatine Phosphokinase Increased: 11 people, 91.67%
Haematochezia (passage of stools containing blood): 10 people, 83.33%
Hypertriglyceridaemia (excess of triglycerides in the blood): 10 people, 83.33%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 9 people, 75.00%
Kidney Infection (Pyelonephritis): 9 people, 75.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 9 people, 75.00%

What are the existing conditions these people have? *

Hiv Infection: 10 people, 83.33%
Weight Decreased: 1 person, 8.33%
Stress And Anxiety: 1 person, 8.33%
Maternal Condition Affecting Foetus (mother condition affecting baby): 1 person, 8.33%
Human Immunodeficiency Virus Transmission: 1 person, 8.33%
Hepatitis C: 1 person, 8.33%
Diarrhea: 1 person, 8.33%
Depression: 1 person, 8.33%
Bipolar Disorder (mood disorder): 1 person, 8.33%
Affective Disorder (mental disorder): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Crixivan and have Abnormal behaviour?

- Check whether Abnormal behaviour is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Crixivan:

Crixivan (6,312 reports)

Browse all side effects of Crixivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abnormal behaviour:

Abnormal behaviour (1,866 drugs)

Browse all the conditions that are associated with Abnormal behaviour:

Abnormal behaviour (2,159 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on indinavir sulfate (the active ingredients of Crixivan) and Crixivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.